TirzaTrim 15mg/0.6ml Injection

TirzaTrim 15mg/0.6ml Injection is a prescription medicine containing tirzepatide, used as part of a medically supervised treatment plan for adults with type 2 diabetes. Tirzepatide acts on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action helps improve glucose-dependent insulin release, lowers inappropriate glucagon secretion, slows gastric emptying, and may reduce appetite. TirzaTrim 15mg is a high-strength presentation and should only be used after careful dose escalation and assessment by a qualified healthcare professional. It is supplied as a multi-dose pen for subcutaneous administration according to the prescribed schedule. Common side effects may include nausea, diarrhoea, vomiting, constipation, indigestion, abdominal discomfort, and reduced appetite. The risk of low blood sugar can increase when tirzepatide is combined with insulin or sulfonylureas. Patients should inform their doctor about pancreatic, kidney, gallbladder, severe digestive, thyroid, pregnancy, or breastfeeding concerns before treatment. Seek urgent medical attention for severe persistent abdominal pain, serious allergic symptoms, breathing difficulty, or neck swelling. TirzaTrim must not be shared and should be stored exactly as directed on the manufacturer’s packaging. Regular monitoring and follow-up remain essential.

Price: Rs. 26470.00

• Manufacturer
  Macter International
• Generic name
  Tirzepatide
• Pack size
  1 Box = 1 Pre-filled Pen
• Availability
  In stock
• Prescription required
  Yes